These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3980108)
21. Blood relatives: artificial oxygen carriers between promise and concern. Shekhar C Chem Biol; 2007 Oct; 14(10):1091-2. PubMed ID: 17961819 [No Abstract] [Full Text] [Related]
22. Blood substitutes as therapy in massive surgery and trauma. Tye RW Prog Clin Biol Res; 1982; 108():79-89. PubMed ID: 6817339 [No Abstract] [Full Text] [Related]
23. An Overview of Two Human Trials of Perfluorocarbon Emulsions in Noncardiac Surgery. Spahn DR; Keipert PE Shock; 2019 Oct; 52(1S Suppl 1):116-118. PubMed ID: 28930917 [No Abstract] [Full Text] [Related]
24. Perfluorochemical-based artificial oxygen carrying red cell substitutes. Lane TA Transfus Sci; 1995 Mar; 16(1):19-31. PubMed ID: 10155703 [TBL] [Abstract][Full Text] [Related]
27. Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport. Faithfull NS Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):797-804. PubMed ID: 1391514 [TBL] [Abstract][Full Text] [Related]
28. Enhancing oxygen solubility using hemoglobin- and perfluorocarbon-based carriers. Centis V; Vermette P Front Biosci (Landmark Ed); 2009 Jan; 14(2):665-88. PubMed ID: 19273094 [TBL] [Abstract][Full Text] [Related]
29. A perfluorochemical emulsion as an oxygen carrier. Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924 [TBL] [Abstract][Full Text] [Related]
30. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
31. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA. Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181 [No Abstract] [Full Text] [Related]
32. Surfactants and perfluorochemical emulsions for use in blood replacement preparations. Geyer RP Int Anesthesiol Clin; 1985; 23(1):25-36. PubMed ID: 3980106 [No Abstract] [Full Text] [Related]
33. [Perfluorochemicals as artificial blood. problems and actual development (author's transl)]. Schnoy N; Pfannkuch F; Beisbarth H Anaesthesist; 1979 Nov; 28(11):503-10. PubMed ID: 118676 [TBL] [Abstract][Full Text] [Related]
35. Oxygen transport by pyridoxylated polyhemoglobin solution. Lenz G; Bissinger U; Benzing H Adv Exp Med Biol; 1990; 277():237-46. PubMed ID: 2096629 [TBL] [Abstract][Full Text] [Related]
36. Red blood cell substitutes: current status. Jones JA Br J Anaesth; 1995 Jun; 74(6):697-703. PubMed ID: 7640127 [No Abstract] [Full Text] [Related]
37. Oxygen-carrying blood substitutes. Messmer K Int Anesthesiol Clin; 1983; 21(2):137-54. PubMed ID: 6862655 [No Abstract] [Full Text] [Related]
38. Perfluorochemical emulsions: potential clinical uses and new developments. Levine EM; Tremper KK Int Anesthesiol Clin; 1985; 23(1):211-30. PubMed ID: 3884515 [No Abstract] [Full Text] [Related]
39. The development and use of oxygen-carrying blood substitutes. Dracker RA Immunol Invest; 1995; 24(1-2):403-10. PubMed ID: 7713599 [TBL] [Abstract][Full Text] [Related]